GI
EW icon

GAMMA Investing’s Edwards Lifesciences EW Stock Holding History

GAMMA Investing’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.09M Buy
12,599
+1,318
+12% +$117K 0.04% 395
2026
Q2 		$1.02M Buy
11,281
+1,225
+12% +$103K 0.04% 395
2026
Q1 		$805K Sell
10,056
-327
-3% -$27K 0.04% 409
2025
Q4 		$885K Buy
10,383
+532
+5% +$43.7K 0.04% 355
2025
Q3 		$766K Buy
9,851
+2,088
+27% +$163K 0.04% 370
2025
Q2 		$607K Buy
7,763
+3,059
+65% +$228K 0.04% 412
2025
Q1 		$341K Sell
4,704
-57
-1% -$4.08K 0.03% 548
2024
Q4 		$352K Buy
4,761
+656
+16% +$45.9K 0.03% 485
2024
Q3 		$271K Buy
4,105
+730
+22% +$53K 0.03% 499
2024
Q2 		$312K Buy
3,375
+788
+30% +$69.8K 0.04% 383
2024
Q1 		$247K Buy
2,587
+292
+13% +$24.5K 0.05% 336
2023
Q4 		$180K Buy
+2,295
New +$160K 0.05% 336

Other funds holding EW

WCG
Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
BRCM
Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
BST
Bath Savings Trust Bath, Maine $966M AUM 9.35% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

GAMMA Investing's EW Position: Q3 2026 in Review

GAMMA Investing increased its Edwards Lifesciences (EW) stake by 12% in Q3 2026, buying an estimated $117K and bringing the position to 12,599 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #395.

GAMMA Investing first reported a position in EW in Q4 2023 and has held it in 12 quarters since. 39 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • GAMMA Investing held 12,599 shares of Edwards Lifesciences worth $1.09M as of Q3 2026.
  • GAMMA Investing bought 1,318 Edwards Lifesciences shares in Q3 2026, an estimated $117K.
  • Edwards Lifesciences made up 0.04% of GAMMA Investing's portfolio in Q3 2026, its #395 holding.
  • GAMMA Investing first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
  • 39 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.